The Hedgehog (Hh) signalling cascade is conserved across evolution and plays an important role in development and disease. In the absence of Hh, activity of the key signal transducer Smoothened (Smo) is downregulated by the Hh receptor Patched (Ptc). However, the mechanisms underlying this inhibition, and especially its release upon ligand stimulation, are still poorly understood, in part because tools for directly following Smo activation at the subcellular level were long lacking. Here we present a high throughput, cell culture assay based on a fluorescent sensor for Drosophila Smo phosphorlyation. Using this approach we could first demonstrate that the graded response to increasing Hh levels observed at the population level can be traced back to threshold responses of individual cells exhibiting differential Hh sensitivity. Second, we screened a small molecule inhibitor library for regulators of Smo phosphorylation. We observed increased Smo sensor fluorescence with compounds aimed at two major target groups, the MAPK signalling cascade and polo and aurora kinases. Biochemical validation confirmed the screen results for selected inhibitors (dobrafenib, tak-733, volasertib) and revealed differences in the mode of Smo activation, demonstrating that the assay is in principle suitable for dissecting the cell biological basis of Hh pathway activation.
Introduction
Hedgehog (Hh) signalling plays an important role in development and disease, and is highly conserved across different branches of the evolutionary tree. A unique feature of the Hh signalling cascade is the sequential use of two receptor-like proteins, the actual Hh binding receptor Patched (Ptc) Since Ptc is structurally a member of the RND family of small molecule transporters 2 , it has been suggested to act as a transporter for small molecules that influence Smo activity. Extensive efforts have therefore been focused on identifying endogenous Smo ligands that may be trafficked by Ptc. In vertebrates, sterols were implicated through a line of evidence that started with the importance of cholesterol metabolism for signal transduction 3, 4 , continued with a detailed biochemical model 5 and just recently was extended to structural biology 6, 7 the CK and GPRK kinases 11, 12 . Phosphorylation protects Smo from ubiquitination by interfering with ubiquitin ligases and through the recruitment of deubiquitinating enzymes 13, 14 . Since ubiquitination promotes internalization of Smo, phosphorylation stabilizes active Smo at the plasma membrane 13, 14 , resembling the effect of sumoylation 15 
Methods

Plasmids
The P-element vectors pUAST or pCasPer using the appropriate inserts were used for the generation of cell culture plasmids. To generate the UAS::smoIP plasmid, the Cell culture S2 cells were cultivated at room temperature in Schneider´s Drosophila Medium (Pan Biotech) supplemented with 10% FBS (ThermoFisher) and pen/strep antibiotics in T25 flasks (TPP). Cell transfection was done using a standard calcium phosphate protocol 24 . For P-element transformation, target plasmid was co-transfected with ∆2-3 helper plasmid 25 at a 10:2 ratio. Stable cell lines were selected on either 300µg/ml hygromycinB (Sigma-Aldrich) or methotrexate 4*10 -7 M (Sigma-Aldrich) for 3 weeks 26 . Clonal selection was done according to protocol 27 . Briefly, S2 feeder cells were irradiated with 23.3 kR. Target cells were diluted to a concentration of 50 cells/ml, mixed with feeder cells (10*10 6 ) in 8ml of full growth medium. 2ml of 1.5% agarose (filter sterilized) were added to the cells and mixed by gentle shaking. Individual clonal colonies were excised in 2-3 weeks after reaching 2-3mm in diameter, the surrounding agar was mechanical softened and cells were placed in 96 well plates (ThermoFisher). Expression from the mtn promoter was induced using 1mM of Inhibitors were used in the following concentrations: OA, 5 nM; IBMX, 24µg/ml, fsk, 80µM; h89, 30µM, dbn, tak-733 and vlt, 15µM if not stated otherwise.
Cl8 cells were cultivated under standard conditions in M3 medium (Sigma-Aldrich, USA), supplemented with 2.5% FBS (ThermoFisher, USA), and 2.5% fly extract (prepared according to the DGRC protocol), insulin at 5µg/ml and pen/strep solution. Western blots 3*10 6 S2 cells were seeded on 6 well plates in 1,5 ml volume and stimulated with 500µL of either Hedgehog or mock conditioned medium for 24h hours. Cells were lysed in lysis buffer (25 mM Tris pH 7.2, 150 mM NaCl, 5 mM MgCl2, 0.2% NP-40, 1 mM DTT, 5% glycerol) on ice in presence of protease (Roche) and phosphatase (Sigma-Aldrich) inhibitor cocktails for 30min. Lysates were boiled for 20sec with loading buffer, cooled on ice an run on bis-tris gradient gels (ThermoFisher). Ptc (Apa 1, 1:250), smo (20C6, 1:100), and tub (12G10, 1:250) antibodies were obtained from DSHB, beta-act (1:5000) from Abcam, GFP antibody was obtained from Clontech.
The HhN antibody (1:500) was a gift of Suzanne Eaton (Dresden). Primary antibody incubation was performed at 4°C overnight, secondary antibody incubation for 1h at RT.
Plasma membrane smo staining
After stimulation for 24h with Hh conditioned medium 2*10 6 cl14 cells were harvested by pipetting and centrifugation, re-suspended in 150uL FACS buffer (0.1% NaN 3 , 0.5% BSA in PEM) containing Smo ab (1:300) and stained for 1h 30min at RT on shaker. Then cells were centrifuged, washed once with 2ml of ice-cold FACS buffer for 10 min, centrifuged and stained with AlexaFluro 647 tagged secondary antiserum (1:500) for 30 min at RT. Cells were then centrifuged, washed, and centrifuged again, re-suspended in 200µL of FACS ice-cold buffer and analyzed by FACS.
Real time qPCR
3*10 6 of S2 cells were treated with inhibitors in 2ml medium in 35mm petri dishes for 24h before RNA extraction. RNA was extracted using Trizol (ThermoFisher). cDNA was synthesized using a first strand cDNA synthesis kit (ThermoFisher) and random primers from 3µg of RNA. qPCR was performed with maxima SYBR green qPCR master mix (ThermoFisher) on a lightCycler 480 (Roche) using the following primer pairs: ptc_F: AGTCCACGAACAATCCGCA ptc_R: TGGGTCGTCTGAATGAGCAG gapdh2_ F: GAGTTTTCGCCCATAGAAAGC gapdh2_R: CGATGCGACCAAATCCATTG 28 Ptc expression was calculated using the ddCt method relative to gapdh2 expression.
Microscopy
Cells were live-imaged 24h after stimulation with Hh condition medium. 2-3h prior to imaging cells were lifted by pipeting and placed in Lab-Tek chambers (ThermoFisher) . Images were taken using Zeiss LSM780 confocal microscope and analyzed by ImageJ.
Data analysis
FACS data was analysed by FlowJo (FlowJo Software, USA). Gating for FSC and SSC axis in each experiment was done according to the control cells. For the screen results, only samples with more than 50% of cells in the chosen gate were taken in to account. Median GFP intensity was calculated for the gated population in each sample. Treatment effects were measured as a difference between signal intensity of inhibitor and a non-stimulated control normalized to the difference between stimulated and non-stimulated controls, hereafter referred to as "normalized response". Analysis and visualization of the screen results was done with the help of the Pandas Python package. All charts represent mean ± sd values with sample sizes indicated in figure legend. Significance levels were calculated using the Mann-Whitney U test implemented in the ScyPy Python package.
Results
The cell-based SmoIP assay allows direct detection of Smo phosphorylation
To develop a system for the direct investigation of Smo activation in cell culture, we chose the Drosophila S2 cell line 29 cassette on the same plasmid. We also switched to hygromycin selection, which was expected to produce a higher, average transgene copy number per cell 26 . Indeed, stimulation of S2 cells transfected with UAS-smoIP tub-Gal4VP16 (in the following abbreviated as UAS-smoIP) with Hh conditioned medium produced a fluorescent signal readily detectable by FACS. However, the proportion of transgenic cells in the population was too low for robust analyses (Fig. 1b) . To increase the fraction of transgenic cells in the population we iteratively sorted and recultured the 10% of cells with highest response to Hh stimulation based on sensor fluorescence. Already after two rounds of sorting about 90% of cells were responsive (Fig 1c) . Since P-element based transgenesis produces random integration in the genome we decided to subclone individual cells to produce genetically homogeneous lines with the desired response properties for use in subsequent experiments. Using a soft agar cloning technique in combination with an irradiated feeder cell layer 27 we obtained and analyzed 20 individual clones harboring UAS-SmoIP insertions. For the following analysis we selected clone 14 (cl14), which showed the highest ratio of induction signal over background pathway activity ( Fig. 1d,e ). As a result of these preparatory experiments we had therefore obtained a stable, genetically homogeneous clone of UAS-SmoIP cells that reproducibly responded to Hh stimulation with a robustly detectable increase in sensor fluorescence.
UAS-SmoIP fluorescence responds as predicted to experimental manipulation
To validate that the cl14 assay correctly reflects endogenous Hh pathway behavior we tested system response to perturbation of known components of the Hh signalling cascade. PKA is the main kinase that phosphorylates Smo and promotes its activation.
Consistently, the small molecule PKA inhibitor h89 31 completely abolished SmoIP fluorescence in response to Hh treatment ( Fig. 2a,b ). To test whether PKA activity was sufficient for the full activation of our assay we treated cells with two PKA activators, forskolin (fsk) and IBMX, that had both previously been shown to work in Drosophila S2 cells 32, 33 . Even though both inhibitors activate PKA by increasing intracellular cAMP levels, they do so by different mechanisms: While fsk stimulates adenylate cyclase activity, IBMX inactivates phosphodiesterases. Importantly, the two PKA activators exhibited consistent effects on SmoIP sensor fluorescence: In both cases, application of the drug had barely any effect on mock treated cl14 cells, but showed pronounced, cooperative activation when acting together with Hh ( Fig.   2a ,c,d), reproducing previously published result for fsk 32 . In contrast, global inactivation of phosphatases by okadaic acid (OA) is sufficient to drive Hh signalling in the basence of ligand 34 . Consistently, OA treatment by itself induced a sensor response exceeding the fluorescence induced by stimulation with Hh alone ( Fig. 2a,e ).
Interestingly, combined treatment of cl14 cells with OA and Hh did not increase As a final test of assay specificity we knocked down several pathway regulators by transfection with dsRNA ( Supplementary Fig. S1 ). Knockdown Summarizing these experiments we could therefore conclude that the cl14 system correctly reports Smo activation in cell culture.
Stimulation of cl14 cells with increased Hh levels reveals cell specific response thresholds
The assay system we had developed and validated gave us an opportunity to determine the Smo response to Hh stimulation quantitatively and with single cell resolution. This quantitative approach promised to shed light on the how target cells may respond to graded Hh signals, a recurring and important theme in developmental biology. We therefore first decided to explore how the cl14 sensor system responded over varying Hh concentrations and stimulation times.
For stimulation of cultured cells a 1:1 mixture of fresh and Hh conditioned medium is typically assumed to provide full pathway activation 35 . We therefore use this mixing ratio to build the time response curve of our assay. Upon stimulation, the fluorescent sensor signal becomes first detectable after 4h and then gradually increases up to 24h under continuous stimulation (Fig. 3a) . This kinetics does not reflect the direct measurement of Smo accumulation rate after Hh stimulation, where an increase of protein level is detectable as soon as 30min after onset of stimulation 36 .
Presumably, the slower kinetics of our system reflects a lower sensitivity of fluorescence measurement compared with immunoblotting, therefore requiring prolonged signal integration and protein stabilization. To maximise the detection window of our assay we fixed stimulation time at 24h throughout all further experiments.
We next explored the volume ratio between conditioned and fresh medium in a range from 1:100 to 1:1 (Fig. 3b) . The system reached saturation at ratio around 1:5, however, we were able to detect pathway activation even at the lowest concentration we tested. Taking advantage of the fact that the FACS based assay provides information about signal intensity for each individual cell we broke the average values presented in (Fig. 3b) (Fig. 3c ). Even though our cl14 assay line is clonally derived from a single cell, each cell in the tested population thus appears to have a different concentration threshold above which it activates its Hh signalling cascade.
A small molecule inhibitor screen suggests an effect of RTK signalling and cell cycle associated kinases on Smo activation
The real power of in-vitro assays such as the one we developed lies in the possibility to perform high throughput (HT) experiments. We therefore decided to optimize our assay for future HT studies. This was facilitated by the fact that S2 cells can be cultivated in suspension, which allowed us to easily implement FACS as a detection system and thus immediately obtain quantitative data. To minimize screening time, a typical problem of FACS based assays, and to increase throughput, we scaled the assay down to 384 well plate format.
As proof of principle we systematically tested a Selleckchem collection of 1130 small molecule inhibitors with known molecular targets (Selleckchem L1100) for effects on Smo phosphorylation state. However, these inhibitors were developed and validated for mammalian systems, and for the majority of them there is no information about their efficacy in Drosophila. We therefore screened each compound at two concentrations, 2µm and 15µM. Cells were pre-incubated with compounds for 30 min, stimulated with either Hh or mock conditioned medium, and analyzed by FACS after 24h (Fig. 4a ). Measuring the effects of inhibitors on Supplementary Fig. S2 , Supplementary table S1). We therefore clustered the compounds according to their molecular targets and computed median response for each of these classes ( Fig. 4b-e , Supplementary table S2 ).
Hits were then identified as clusters where multiple inhibitors targeting one or more components of the same pathway exhibited a consistent effect on sensor fluorescence. Correlating the observed effect for each such cluster between experiments performed at different concentrations and in the presence vs. absence of Hh stimulation demonstrated reproducibility and robustness of our assay ( Supplementary Fig. S2 ).
Clustering compounds by targets in this way revealed several candidate pathways whose inhibition appeared to modulate Smo activation. Sensor fluorescence was increased by compounds targeting various RTKs (Fig. 4b-e 
Validation of hits via independent, secondary assays confirms the links between MAPK pathway or polo kinase inhibitors and Smo activation.
The mTOR protein is part of MTORC1 complex that acts as a central regulator of cell growth and protein synthesis 37 . Since Smo protein is constantly turned over, its accumulation in response to Hh, especially over the long stimulation period of our assay, involves de novo protein synthesis. The negative role of mTOR inhibition on
SmoIP sensor accumulation was therefore not unexpected, and we decided to focus instead on the compound clusters causing increased sensor fluorescence. We also decided to exclude the cluster of HDAC inhibitors, as epigenetic modifiers most likely affect Smo activation only indirectly.
From the remaining clusters, we selected three highly scoring compounds: To interfere with signalling downstream of RTKs at two different levels we chose the Raf inhibitor dabrafenib (dbn) 38 (Fig. 6b ). Induction of sensor fluorescence by all compounds was concentration dependent ( Supplementary Fig.   S3 ), further validating the initial observations made in HT mode and suggesting that the observed effects were specific.
However, assay conditions, including expression levels and stimulation times,
were optimized to achieve the maximal fluorescence signal. Phosphorylation of the sensor does therefore not necessarily directly reflect activation of the endogenous signal cascade. We therefore validated our FACS and microscopy results by methodologically independent biochemical experiments in our cl14 reporter cell line ( Fig. 6c ), as well as in wildtype S2 cells ( Fig. 6d ) and in cl8 cells (Fig. 6e) , an unrelated cell line that expresses the entire Hh signalling cascade including the transcription factor Ci and is thus endogenously sensitive to Hh 30 . Stimulation with hh conditioned medium or inhibitor treatment of cl14 cells individually led to increased SmoIP protein levels. This response was further enhanced by combining ligand and inhibitors (Fig. 6c) . A similar effect, albeit with a reduced dynamic range, was also seen for endogenous Smo protein in S2 cells (Fig. 6d ) and in cl8 cells (Fig.   6e ). Thus, activation and accumulation of Smo in response to these compounds is not merely an artefact of our fluorescent assay system. In addition, extracellular labelling Hh treatment ( Fig. 6c-d) , presumably reflecting the Hh induced internalization and degradation. However, Ptc is also a target gene of the Hh pathway. Hence, Hh stimulation caused an increase in Ptc levels in the endogenously signalling competent cl8 cells (Fig. 6e ). Ptc levels decreased in all three tested cell types following treatment with tak-733 or dbn ( Fig. 6c-e ). We excluded that these inhibitors inadvertently induced Hh expression ( Supplementary Fig. S5 ). Instead, the reduction in Ptc protein levels in response to dbn and tak-733 was correlated with a reduction in Ptc transcription (Fig. 6f) , which may suffice to explain the greater baseline activation and increased Hh sensitivity of the cells treated with the two inhibitors. Smo would in this case still be activated by the endogenous signalling machinery, resembling e.g. pathway activation by Ptc RNAi knockdown.
In contrast, treatment with the polo inhibitor vlt did not affect basal Ptc protein levels in either of the three cell lines ( Fig. 6c-e ) nor Ptc transcription in S2 cells (Fig.   6f ). At the protein level, treatment of unstimulated cl14 cells with vlt stabilized
SmoIP comparable to treatment with Hh, even though the induced reporter fluorescene was substantially stronger. Co-stimulation with vlt and Hh further increased both reporter fluorescence and accumulation of SmoIP (Fig. 6c) . The same effect was seen for endogenous Smo in S2 cells (Fig. 6d ). In the signaling competent cl8 cells, vlt also induced a strong increase in basal Smo levels. However, the pronounced cooperativity with Hh was absent (Fig. 6e ). Treating cl8 cells with Hh upregulated Ptc levels, confirming signal transduction down to the transcription level.
Importantly, this was not seen following treatment with vlt, despite the observed stabilization of Smo (Fig. 6e ). Thus vlt, unlike dbn or tak-733, does not act through activation of the endogenous signalling machinery, but influences Smo phosphorylation and accumulation through a mechanism that does not activate downstream signalling. Consistent with the notion that dbn/tak-733 and vlt act through different mechanisms, the PKA activators IBMX and fsk, which are able to enhance fluorescence of endogenously activated Smo (Fig. 2, Supplementary Fig.   S5 ), show no such cooperative effect with vlt ( Supplementary Fig. S5 ). In contrast, co-treatment with the phosphatase inhibitor OA enhances Smo activation by vlt both at the protein and fluorescence level ( Supplementary Fig. S5 ).
In summary, the small molecule inhibitors dbn and tak-73 that target Raf and MEK, respectively, appear to downregulate Ptc expression in a Ci independent manner, thereby activating Smo through the endogenous signalling machinery. In contrast, the polo inhibitor vlt promotes Smo phosphorylation and accumulation via a different mechanism that fails to trigger downstream signal transduction. While our present experiments cannot dissect these mechanisms in detail, this clearly demonstrates that the assay is in principle able to uncover Smo activation independent of the underlying molecular mechanism, and is thus fit for purpose.
Discussion
We have presented a novel, FACS In addition to providing quantiative data from single experiments, our assay is scaleable to high throughput mode, up to 384 well plates. We performed a proof of principle screen using a library of small molecules with known molecular targets.
Grouping compounds by these targets revealed several compound clusters whose members consistently affected Smo phosphorylation. The emergence of these clusters by itself provides a strong validation for the screening results, even though we are not able to extrapolate from the available information on the individual compounds to specific targets in the fly system. Although it was beyond the scope of this study to identify the primary targets of these hits we were able to define a putative mechanism of action for two of the selected chemicals: Inhibition of the MAPK cascade by dbn 
